# Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy

> **NCT02104414** · PHASE4 · TERMINATED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 11 (actual)

## Conditions studied

- Hemorrhoid

## Interventions

- **DRUG:** Exparel
- **DRUG:** Bupivacaine HCl with Epinephrine
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT02104414
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104414, "Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02104414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*